QA: Sybleu Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818674_2023_Sybleu_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001818674, Sybleu Inc

  xvar xval
0 AssetsCurrent 66,850
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 9,529
4 LiabilitiesCurrent 164,640
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 161,698
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,615
9 ResearchAndDevelopmentExpense 5,058
10 remainder_Expenses 47,400
11 remainder_Revenues 11,700
12 remainder_NetIncome -188,973
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 76,379
1 Liabilities 326,338
2 Expenses 68,073
3 Revenues 11,700
4 StockholdersEquity -249,959
5 NetIncome -245,346
6 ComprehensiveNetIncome -245,346
7 BaseVar 335,732
8 EconomicCapitalRatiobeforeLimitedLiability -3.92
9 EconomicCapitalRatio 0.411

Edgar->Model Mapping

Feature Distribution

Change over Time